ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Axsome Therapeutics (AXSM) Technical (Analysis) Reports Axsome Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Axsome Therapeutics (AXSM)

Technical Analysis Report for NASDAQ stock AXSM Axsome Therapeutics. Dated: 19 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock AXSM Axsome Therapeutics then click here. or read Experts views on Axsome Therapeutics or Forecast & share price targets of Axsome Therapeutics

Axsome Therapeutics Opened at 147.18 and Closed at: 152.65, which is 3.7% of previous session's close. It moved within a range of 147.18 and 154.49
The session was a Bullish session with an average volume of 975200, which is 59.75% of previous session's volumes.

  • The stock has shown an up move, and its short term trend is also positive and in an uptrend.
  • The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
  • The stock has shown an up move, and its long term trend is also positive and in an uptrend.

A Dead cross was found 6 days back on short term averages

Support for tomorrow is 149.92 and resistance for tomorrow is 157.23
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 148.39, 144.13 resistance for tomorrow's hourly charts is 155.7, 158.75

10 Day SMA for Axsome Therapeutics (AXSM) is 147.97 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Axsome Therapeutics (AXSM) is 148.47 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Axsome Therapeutics (AXSM) is 139.98 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 128.19 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Axsome Therapeutics is 118.48 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Axsome Therapeutics is at 148.47 and 200 DMA is at 118.48, while 50 DMA and 100 DMA are at 139.98 and 128.19 respectively

Axsome Therapeutics (AXSM) moving average of 20 SMA is at 148.47 and 20 EMA is at 146.98

Axsome Therapeutics (AXSM) moving average of 50 SMA is at 139.98 and 50 EMA is at 140.38

Axsome Therapeutics (AXSM) moving average of 100 SMA is at 128.19 and 100 EMA is at 131.66

Axsome Therapeutics (AXSM) moving average of 200 SMA is at 118.48 and 200 EMA is at 121.03

Trillium Therapeutics has performed better than Axsome Therapeutics in short term. You could have earned much better returns by investing in Trillium Therapeutics, about 2.16% more returns!

Axsome Therapeutics has performed better than Tg Therapeutics in short term. Holding Axsome Therapeutics could be a better choice for now!

Neuronetics Inc has performed better than Axsome Therapeutics in short term. You could have earned much better returns by investing in Neuronetics Inc, about 4.72% more returns!

Axsome Therapeutics has performed better than Scynexis Inc in short term. Holding Axsome Therapeutics could be a better choice for now!

Neogen Corporation has performed better than Axsome Therapeutics in short term. You could have earned much better returns by investing in Neogen Corporation, about 23.72% more returns!

Meiragtx Holdings has performed better than Axsome Therapeutics in short term. You could have earned much better returns by investing in Meiragtx Holdings, about 5.49% more returns!

Axsome Therapeutics has performed better than Medpace Holdings in short term. Holding Axsome Therapeutics could be a better choice for now!

Apellis Pharmaceuticals has performed better than Axsome Therapeutics in short term. You could have earned much better returns by investing in Apellis Pharmaceuticals, about 23.55% more returns!

Capricor Therapeutics has performed better than Axsome Therapeutics in short term. You could have earned much better returns by investing in Capricor Therapeutics, about 381.5% more returns!

Cocrystal Pharma has performed better than Axsome Therapeutics in short term. You could have earned much better returns by investing in Cocrystal Pharma, about 7.85% more returns!

Crispr Therapeutics has performed better than Axsome Therapeutics in short term. You could have earned much better returns by investing in Crispr Therapeutics, about 9.02% more returns!

Axsome Therapeutics has performed better than Dynavax Technologies in short term. Holding Axsome Therapeutics could be a better choice for now!

National Vision has performed better than Axsome Therapeutics in short term. You could have earned much better returns by investing in National Vision, about 5.52% more returns!

Axsome Therapeutics has performed better than Eyegate Pharmaceuticals in short term. Holding Axsome Therapeutics could be a better choice for now!

Axsome Therapeutics Technical analysis of indicators

Price action analysis of Axsome Therapeutics (AXSM) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.

ADX buy sell signal for Axsome Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.

MACD generated a SELL signal for Axsome Therapeutics in short term but the sell signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Axsome Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up

CCI has generated a buy signal for Axsome Therapeutics in short term and BUY signal is strong.

RSI is generating a BUY signal in short term and the buying is gaining momentum.

MRSI is in positive zone. This is a BUY zone

Stock of Axsome Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 148.52 and Axsome Therapeutics AXSM stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Axsome Therapeutics AXSM stock. Volume based technical analysis of Axsome Therapeutics AXSM stock is negative.

Axsome Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock AXSM Axsome Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And AXSM Experts View which covers a lot of information including buying and selling signals

AXSM future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Axsome Therapeutics or View Candle Stick Charts here

Chart Axsome Therapeutics (AXSM)  Technical (Analysis) Reports Axsome Therapeutics [

Videos related to: Axsome Therapeutics (AXSM) Technical (Analysis) Reports Axsome Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Axsome Therapeutics (AXSM)  Technical (Analysis) Reports Axsome Therapeutics [

 

Back to top